Galler; Ricardo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Galler; Ricardo.The latest application filed is for "method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions".

Company Profile

2.10.13

Galler; Ricardo - Rio de Janeiro N/A BR
Galler; Ricardo - Niteroi BR
Galler; Ricardo - Pendotiba BR
Galler; Ricardo - Manguinhos BR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of DNA and chimeric virus vaccines Grant 10,357,558 - Alves , et al. July 23, 2	2019-07-23
Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions Grant 10,286,059 - Bonaldo , et al.	2019-05-14
Method For The Production Of Recombinant Virus, Dna Constructs, Recombinant Virus And Vaccine Compositions App 20170360916 - Bonaldo; Myrna Cristina ; et al.	2017-12-21
Method For The Production Of Recombinant Virus, Dna Constructs, Recombinant Virus And Vaccine Compositions App 20170157237 - Bonaldo; Myrna Cristina ; et al.	2017-06-08
Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions Grant 9,539,317 - Bonaldo , et al. January 10, 2	2017-01-10
Method For The Production Of Recombinant Virus, Dna Constructs, Recombinant Virus And Vaccine Compositions App 20160367656 - Bonaldo; Myrna Cristina ; et al.	2016-12-22
Method For The Production Of Recombinant Virus, Dna Constructs, Recombinant Virus And Vaccine Compositions App 20150024003 - Bonaldo; Myrna Cristina ; et al.	2015-01-22
Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions Grant 8,828,687 - Bonaldo , et al. September 9, 2	2014-09-09
Lentivirus Vaccine Based On The Recombinant Viral Vaccine Against Yellow Fever App 20120321655 - Bonaldo; Myrna Cristina ; et al.	2012-12-20
Method, Kit, Plasmid And Composition For Inducing An Immune Response To Dengue Virus, On The Basis Of Dna And Chimeric Virus Vaccines App 20120251570 - Alves; Ada Maria de Barcelos ; et al.	2012-10-04
Method for the Production of Recombinant Virus, DNA Constructs, Recombinant Virus and Vaccine Compositions App 20100297167 - Bonaldo; Myrna Cristina ; et al.	2010-11-25
Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents App 20060159704 - Bonaldo; Mirna C. ; et al.	2006-07-20
Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents App 20030194801 - Bonaldo, Mirna C. ; et al.	2003-10-16
Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA Grant 6,589,522 - Galler , et al. July 8, 2	2003-07-08
Yellow fever infectious cDNA and plasmids Grant 6,171,854 - Galler , et al. January 9, 2	2001-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.